The applications of surgical sealants, glues and wound closure are many and are rapidly multiplying as more credible data is generated on each application and as physicians gain comfort in working with the products in routine clinical practice.
Below is a sample of surgical sealants, glues and wound closure applications by clinical area:
Source: MedMarket Diligence, LLC; [...]
(Below is an excerpt from "Surgical Sealants, Glues and Wound Closure Worldwide Market, 2009-2013.")
Natural hemostats such as gelatin, collagen and thrombin were first developed as hemostatic agents, followed by mixes and fibrin sealants. More recently, companies have introduced synthetic sealants and hemostats that accelerate the process of blood clotting and provide a stronger seal that [...]
Although healing of all surgical and procedure-based wounds might be improved through use of adjunctive surgical closure and securement products, it is likely that increased usage of these products will be limited, on economic grounds, to a fraction of procedures. It is realistically estimated that 10%–15% of these procedures would benefit from increased use of [...]
Although market growth in some Eastern European countries that have recently joined the EU is more rapid than in the west, the major European markets in terms of size are still Germany, United Kingdom, France, Italy and Spain. The market for advanced wound closure and securement products is relatively mature in Europe and the scope [...]
The use of products such as tapes and sutures for wound closure and securement leads to faster wound healing with less risk of contamination by debris and infectious agents, and with improved cosmetic outcomes. Failure to use these products can lead to significant complications, infections, significant delays to healing, and potentially loss of life [...]
Applications of fibrin sealant are gaining caseload in cardiovascular, neurological, orthopedic, urological dermal, and soon, as preceded in this clinical trial in progess, ophthalmology:
Safety and efficacy of fibrin sealant in vitreoretinal surgery http://clinicaltrials.gov/ct2/show/NCT01022164
The criteria for patient inclusion in this trial are those having vitreoretinal procedures that require suture.
Several companies active in the area of surgical sealants [...]
Covidien has announced the launch of DuraSeal sealant for the intra-operative sealing of dural membrane during spine procedures. In the U.S. alone, 150,000 spine surgeries annually are associated with leaks of cerebrospinal fluid (CSF), with each incident being reponsible for nearly $6,500 in additional costs.
What is telling in Covidien's emphasis on cost is that [...]
A useful starting point for determining which adjunctive surgical closure and securement products are appropriate for different wound healing treatments is to recognize the major distinction between different wound types. Surgical wounds are usually appropriate for treatment with adjunctive surgical closure and securement products because they are created under clean conditions, the usual acute healing [...]
The areas of greatest opportunity in medtech are those which have already demonstrated they have plenty of upside, even if a robust number of competitors have already begun targeting them.
Areas of the strongest market growth in medical technologies that we are seeing have emerged out of the major segments we have tracked in recent analyses. [...]
CryoLife's BioFoam, a protein hydrogel, received FDA approval today to begin an IDE for sealing of liver parenchymal tissue when conventional methods (e.g., ligature) prove ineffective.
The approved IDE is for a prospective, multicenter, randomized feasibility study evaluating safety outcomes of BioFoam as compared to a standard topical hemostatic agent. The feasibility investigation will be conducted [...]
Contact:
